派林生物 (000403.SZ)

今开: 最高: 成交量:

昨收: 最低: 成交额:

+ 收藏

现金流量表(派林生物)

导出到EXCEL
报表日期选择
  • 常用日期查询
  • 自定义年度查询
    日期范围
    报告期
    报告类型
    显示选项
关 闭
完整财报对比
2023年三季报2023年中报2023年一季报2022年年报2022年三季报2022年中报2022年一季报
上市前/上市后 上市后上市后上市后上市后上市后上市后上市后
报表类型 合并报表合并报表合并报表合并报表合并报表合并报表合并报表
一、经营活动产生的现金流量
 销售商品、提供劳务收到的现金(元) 1,573,400,641.94996,145,957.03545,199,763.042,056,846,038.181,480,903,204.861,004,350,309.57462,115,286.85
 收到的税费返还(元) 171,077.8111,099.72154,954.64-14,021.0814,021.08256,277.14
 收到其他与经营活动有关的现金(元) 79,161,688.8335,774,023.1117,503,338.6938,417,763.7370,739,466.9439,109,220.9613,164,936.27
 经营活动现金流入小计(元) 1,652,733,408.581,031,931,079.86562,858,056.372,095,263,801.911,551,656,692.881,043,473,551.61475,536,500.26
 购买商品、接受劳务支付的现金(元) 767,742,600.82454,996,653.15215,424,697.54760,880,928.15576,251,502.35342,255,598.93167,704,415.38
 支付给职工以及为职工支付的现金(元) 221,731,407.37149,320,610.8487,779,122.80294,130,519.43213,964,567.50154,309,800.12103,316,558.37
 支付的各项税费(元) 157,698,066.31118,716,426.3679,248,539.96172,004,466.74133,529,355.5193,584,838.0043,705,075.96
 支付其他与经营活动有关的现金(元) 279,828,135.90152,512,966.3973,840,968.51344,029,024.16351,107,144.80225,081,453.6182,772,558.23
 经营活动现金流出小计(元) 1,427,000,210.40875,546,656.74456,293,328.811,571,044,938.481,274,852,570.16815,231,690.66397,498,607.94
 经营活动产生的现金流量净额(元) -156,384,423.12-524,218,863.43-228,241,860.95-
二、投资活动产生的现金流量
 收回投资收到的现金(元) 470,000,000.00280,000,000.00130,000,000.00343,000,000.00213,000,000.00180,000,000.00-
 取得投资收益收到的现金(元) 2,288,971.591,386,067.47123,766.013,037,839.661,495,111.521,047,387.87-
 处置固定资产、无形资产和其他长期资产收回的现金净额(元) 8,844.661,000.00-445,635.69501,410.702,090.701,200.70
 收到其他与投资活动有关的现金(元) 57,029,305.9138,832,045.64-101,180,487.65101,043,444.0016,242,500.001,287,840.00
 投资活动现金流入小计(元) 529,327,122.16320,219,113.11130,123,766.01447,663,963.00316,039,966.22197,291,978.571,289,040.70
 购建固定资产、无形资产和其他长期资产支付的现金(元) 303,753,596.70217,525,425.33101,793,113.45378,640,955.65247,744,938.36155,186,511.4970,004,630.31
 投资支付的现金(元) 698,000,000.00440,000,000.00200,000,000.00593,000,000.00513,000,000.00413,000,000.00220,000,000.00
 支付其他与投资活动有关的现金(元) 285,373.70--32,400,000.0022,400,000.0022,400,000.0020,000,000.00
 投资活动现金流出小计(元) 1,002,038,970.40657,525,425.33301,793,113.451,004,040,955.65783,144,938.36590,586,511.49310,004,630.31
 投资活动产生的现金流量净额(元) -472,711,848.24-337,306,312.22-171,669,347.44-556,376,992.65-467,104,972.14-393,294,532.92-308,715,589.61
三、筹资活动产生的现金流量
 吸收投资收到的现金(元) 6,840,702.43700,000.00700,000.002,509,576.09-527,342.082,509,576.091,418,463.63
  其中:子公司吸收少数股东投资收到的现金(元) 700,000.00700,000.00-----
 取得借款收到的现金(元) 380,049,022.62279,133,022.62120,744,450.00481,791,433.80378,874,563.80242,544,073.80112,844,073.80
 收到其他与筹资活动有关的现金(元) 3,109.62-6,918.08-588.60316.69172.72
 筹资活动现金流入小计(元) 386,892,834.67279,833,022.62121,451,368.08484,301,009.89378,347,810.32245,053,966.58114,262,710.15
 偿还债务支付的现金(元) 261,913,399.00177,813,399.0078,610,000.00255,326,791.60189,221,987.2250,000,000.0010,000,000.00
 分配股利、利润或偿付利息支付的现金(元) 64,693,112.223,507,097.482,345,432.6150,463,023.5250,081,891.746,576,137.923,264,006.97
  其中:子公司支付给少数股东的股利、利润(元) ---800,000.00800,000.00--
 支付其他与筹资活动有关的现金(元) 31,834,169.7828,666,427.572,396,497.0830,051,070.2922,563,239.304,059,606.13756,223.71
 筹资活动现金流出小计(元) 358,440,681.00209,986,924.0583,351,929.69335,840,885.41261,867,118.2660,635,744.0514,020,230.68
 筹资活动产生的现金流量净额(元) 28,452,153.6769,846,098.5738,099,438.39148,460,124.48116,480,692.06184,418,222.53100,242,479.47
四、汇率变动对现金及现金等价物的影响(元) 64,616.4778,428.73-27,896.72-1,189,516.09-1,054,849.62-362,641.35-147,581.65
五、现金及现金等价物净增加额(元) -218,461,879.92-110,997,361.80-27,033,078.21115,112,479.17-74,875,006.9819,002,909.21-130,582,799.47
 加:期初现金及现金等价物余额(元) 1,000,535,509.131,000,270,509.131,000,270,509.13885,158,029.96885,158,029.96885,158,029.96885,158,029.96
 期末现金及现金等价物余额(元) 782,073,629.21889,273,147.33973,237,430.921,000,270,509.13810,283,022.98904,160,939.17754,575,230.49
补充资料:
 净利润(元) -143,000,998.94-587,690,140.23-221,591,411.72-
 资产减值准备(元) ----124,406.76---
 固定资产和投资性房地产折旧(元) -57,129,419.88-102,771,076.00-50,816,632.87-
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧(元) -57,129,419.88-102,768,702.68-50,816,632.87-
     投资性房地产折旧(元) ---2,373.32---
 无形资产摊销(元) -8,231,821.82-14,849,661.27-6,591,138.37-
 长期待摊费用摊销(元) -2,097,089.81-4,427,264.62-2,138,781.36-
 处置固定资产、无形资产和其他长期资产的损失(元) --12,023.17--438,082.69-8,771.85-
 固定资产报废损失(元) -1,108,442.80-3,589,236.28-362,536.73-
 公允价值变动损失(元) --5,656,024.04--4,929,120.51--343,428.01-
 财务费用(元) --21,764,905.07--41,210,562.08--19,034,789.38-
 投资损失(元) --2,593,788.88--3,037,839.67--1,595,637.44-
 递延所得税(元) --2,178,243.46--27,938,034.60--9,341,447.84-
  其中:递延所得税资产减少(元) --137,853.88--21,747,390.00--4,607,453.90-
 递延所得税负债增加(元) --2,040,389.58--6,190,644.60--4,733,993.94-
 存货的减少(元) --267,097,180.26-115,512,834.92-6,528,084.13-
 经营性应收项目的减少(元) -286,961,551.50--329,067,406.10--101,114,740.62-
 经营性应付项目的增加(元) --40,524,958.15-70,942,984.52-56,007,124.58-
 其他(元) -2,227,204.05-10,597,781.71-7,037,440.25-
 现金的期末余额(元) -889,273,147.33-1,000,270,509.13-904,160,939.17-
 减:现金的期初余额(元) -1,000,270,509.13-885,158,029.96-885,158,029.96-
 现金及现金等价物的净增加额(元) --110,997,361.80-115,112,479.17-19,002,909.21-
公告日期 2023-10-312023-08-242023-04-292023-04-292022-10-312022-08-302022-04-30
审计意见(境内) 标准无保留意见
原始财报文件下载 下载财报(PDF)下载财报(PDF)下载财报(PDF)下载财报(PDF)下载财报(PDF)下载财报(PDF)下载财报(PDF)

前瞻产业研究院